These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33899786)

  • 21. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
    Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
    Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma.
    Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q
    Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.
    Schoolmeester JK; Dao LN; Sukov WR; Wang L; Park KJ; Murali R; Hameed MR; Soslow RA
    Am J Surg Pathol; 2015 Mar; 39(3):394-404. PubMed ID: 25517951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
    Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
    Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular PEComas are frequently melanotic and TFE3-translocated: report of two cases including the first description of PRCC-TFE3 fusion in PEComa.
    Gao Y; Chen G; Chow C; Io I; Wong EWN; Tsui WMS; Lam WY; To KF; Chan JKC; Cheuk W
    Virchows Arch; 2021 May; 478(5):1025-1031. PubMed ID: 32676967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
    Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
    Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
    Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
    Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
    Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
    Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear Cell Stromal Tumor of the Lung: Clinicopathologic, Immunohistochemical, and Molecular Characterization of Eight Cases.
    Odintsov I; Isaacson A; Fritchie KJ; Hung YP; Khoshnoodi P; Sholl LM; Fletcher CDM; Anderson WJ
    Mod Pathol; 2024 Oct; 38(1):100632. PubMed ID: 39424226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.
    Suurmeijer AJH; Song W; Sung YS; Zhang L; Swanson D; Fletcher CDM; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2019 Sep; 58(9):643-649. PubMed ID: 30920708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
    Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
    Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
    Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
    Lee SJ; Yang WI; Chung WS; Kim SK
    Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
    Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
    J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
    Chang IW; Huang HY; Sung MT
    Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.